This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mallat, Z. Articles by Tedgui, A. Search for Related Content PubMed Articles by Mallat, Z. Articles by Tedgui, A. Related Collections Related Article

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:809.)
© 2008 American Heart Association, Inc.

Editorials

HDL, PTX3, and Vascular Protection

Ziad Mallat; Alain Tedgui

From Inserm U 689, Centre de Recherche Cardivasculaire, Hôpital Lariboisière, Paris, France.

Correspondence to Ziad Mallat, Inserm U689, Hôpital Lariboisière, 41 Bd de la Chapelle, 75010 Paris, France. E-mail ziad.mallat@inserm.fr

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The superfamily of pentraxins consists of evolutionary conserved acute phase proteins characterized by the presence of a multimeric structural motif, the pentraxin domain (reviewed in¹). C-reactive protein and serum amyloid P represent the short pentraxin arm of this family and are mainly produced by the liver. The long pentraxins were identified more recently as cytokine-inducible molecules expressed in a variety of tissues, and differ from the short pentraxins by the presence of a long N-terminal domain coupled to the C-terminal pentraxin domain. PTX3 was the first recognized member of this family, identified as an interleukin (IL)-1 or tumor necrosis factor (TNF)-inducible gene in several cell types but not in hepatocytes, which contrasts with the short pentraxin CRP, known to be produced in the liver and primarily induced in response to IL-6. Several cell types have been shown to produce significant amounts of PTX3 on activation, including fibroblasts, adipocytes, chondrocytes, or mononuclear phagocytes. Myeloid dendritic cells appear to produce the highest amounts of PTX3 in response to Toll-like receptor engagement and proinflammatory cytokines. In fact, PTX3 is primarily known for its ability to bind selected pathogens and the complement component C1q, and to activate the classical complement pathway, facilitating pathogen recognition by macrophages and dendritic cells, and leading to the induction of a protective immune response.¹ Recent studies have also elegantly shown that PTX3 is stored in specific neutrophil granules, the neutrophil extracellular traps, is rapidly released in response to microbial challenge and inflammatory signals, and plays a critical role . . . [Full Text of this Article]

Related Article:

Long Pentraxin 3, a Key Component of Innate Immunity, Is Modulated by High-Density Lipoproteins in Endothelial Cells

Giuseppe Danilo Norata, Patrizia Marchesi, Angela Pirillo, Patrizia Uboldi, Giulia Chiesa, Virginia Maina, Cecilia Garlanda, Alberto Mantovani, and Alberico Luigi Catapano
Arterioscler Thromb Vasc Biol 2008 28: 925-931. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				G. D. Norata, P. Marchesi, V. K. Pulakazhi Venu, F. Pasqualini, A. Anselmo, F. Moalli, I. Pizzitola, C. Garlanda, A. Mantovani, and A. L. Catapano Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis Circulation, August 25, 2009; 120(8): 699 - 708. [Abstract] [Full Text] [PDF]